---
title: "CNBX Pharmaceuticals (CNBX) stock: news and investor profile"
url: "https://aibio.space/companies/cnbx-pharmaceuticals/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "CNBX Pharmaceuticals Inc. (OTC: CNBX), United States. The directory classifies it as Biotechnology."
---

CNBX CNBX Pharmaceuticals Inc. OTC · United States

# CNBX Pharmaceuticals (CNBX) news

Top story · Oct 1, 2026 · SEC filing 8-K

## [CNBX Pharmaceuticals changes its auditor](https://www.sec.gov/Archives/edgar/data/1343009/000168316826007522/cnbx_8k.htm)

On the same date, the Board of Directors of the Company engaged Vilki & Co-#1 Luxor Palace, Gandhi Smruti Bhavan, Gujarat, India 394651 (the “New Accounting Firm”) as its new independent accounting firm as of and for the year ended August 31 st , 2026.

Source: [8-K filed Oct 1, 2026 on SEC EDGAR](https://www.sec.gov/Archives/edgar/data/1343009/000168316826007522/cnbx_8k.htm)

## Latest CNBX Pharmaceuticals news

We have not published a story on CNBX Pharmaceuticals yet. When there is news, it will appear here.

## CNBX Pharmaceuticals at a glance

- **Ticker**: CNBX

- **Listing**: OTC

- **Country**: United States

- **Cash, May 31, 2026**: $9,487

### Related companies

- [United Therapeutics](https://aibio.space/companies/united-therapeutics/) NASDAQ: UTHR
- [Kalaris Therapeutics](https://aibio.space/companies/kalaris-therapeutics/) NASDAQ: KLRS
- [Design Therapeutics](https://aibio.space/companies/design-therapeutics/) NASDAQ: DSGN
- [Manhattan Scientifics](https://aibio.space/companies/manhattan-scientifics/) OTC: MHTX
- [Scholar Rock Holding](https://aibio.space/companies/scholar-rock/) NASDAQ: SRRK
- [IGC Pharma](https://aibio.space/companies/igc-pharma/) AMEX: IGC
- [Anavex Life Sciences](https://aibio.space/companies/anavex-life-sciences/) NASDAQ: AVXL
- [Abpro Holdings](https://aibio.space/companies/abpro/) OTC: ABPO

### Also on OTC

- [CapForce](https://aibio.space/companies/capforce/) CFOR
- [BIOTRICITY INC.](https://aibio.space/companies/biotricity/) BTCY
- [Sigyn Therapeutics](https://aibio.space/companies/sigyn-therapeutics/) SIGY
- [AFFYMAX INC](https://aibio.space/companies/affymax/) AFFY
- [PONIARD PHARMACEUT](https://aibio.space/companies/poniard-pharmaceut/) PARD
- [VirExit Technologies](https://aibio.space/companies/virexit-technologies/) VXIT

## CNBX Pharmaceuticals annual financials

| Line | FY ended Aug 31, 2025 | FY ended Aug 31, 2024 |
|---|---|---|
| Revenue | [$0](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) | [$130,074](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) |
| Research and development | [$0](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) | [$194,788](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) |
| Net income (loss) | [-$313,976](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) | [-$695,198](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) |
| Cash from operations | [-$171,305](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) | [-$244,269](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) |
| Cash and equivalents | [$15,111](https://www.sec.gov/Archives/edgar/data/1343009/000168316826005078/) | [$26,416](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/) |

Latest balance sheet, May 31, 2026 (10-Q): cash and equivalents $9,487.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about CNBX Pharmaceuticals

What is the ticker symbol of CNBX Pharmaceuticals?

CNBX Pharmaceuticals Inc. trades under the ticker CNBX on OTC.

Where is CNBX Pharmaceuticals listed?

CNBX Pharmaceuticals Inc. is listed on OTC.

What is the SEC CIK of CNBX Pharmaceuticals?

The SEC Central Index Key (CIK) for CNBX Pharmaceuticals Inc. is 1343009. Its filings are on SEC EDGAR.

How many shares does CNBX Pharmaceuticals have outstanding?

1,605,768,095 shares as of 2026-06-17, per the cover page of its 10-Q filed 2026-06-24.

Which country or territory is CNBX Pharmaceuticals listed under?

Our directory records CNBX Pharmaceuticals Inc. under United States.

What does CNBX Pharmaceuticals do?

Our directory classifies CNBX Pharmaceuticals Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of CNBX Pharmaceuticals?

The ISIN recorded for CNBX Pharmaceuticals Inc. is US13764M2098.

Does aibio.space cover CNBX Pharmaceuticals?

aibio.space lists CNBX Pharmaceuticals Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is CNBX Pharmaceuticals incorporated?

SEC records list its state or country of incorporation as NV.

What was CNBX Pharmaceuticals's revenue last year?

$0 for the fiscal year ended Aug 31, 2025, as reported to the SEC.

Is CNBX Pharmaceuticals profitable?

CNBX Pharmaceuticals Inc. reported a net loss of $313,976 for the fiscal year ended Aug 31, 2025, and used $171,305 of cash in operations, per its annual report to the SEC.

How much does CNBX Pharmaceuticals spend on research and development?

$0 in the fiscal year ended Aug 31, 2025, per its annual report.

How much cash does CNBX Pharmaceuticals have?

$9,487 in cash at May 31, 2026, per its 10-Q.

What is CNBX Pharmaceuticals's market cap?

We do not publish live share prices. In its annual report, CNBX Pharmaceuticals Inc. put the market value of shares held by non-affiliates (public float) at $251,840 as of Aug 31, 2025.

Is CNBX Pharmaceuticals a smaller reporting company?

SEC records list CNBX Pharmaceuticals Inc.'s filer category as: <br>Emerging growth company.

## Investor discussion: CNBX Pharmaceuticals

Members talk about CNBX Pharmaceuticals (CNBX). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at CNBX Pharmaceuticals, newest first. Each line links the filing it comes from.

1. 2026-10-01 Legal Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1343009/000168316826007522/cnbx_8k.htm)
2. 2025-12-01 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/cnbx_i10k-083125.htm)
3. 2024-11-29 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1343009/000168316824008433/cnbx_i10k-83124.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:CNBX on TradingView](https://www.tradingview.com/symbols/OTC-CNBX/).

## SEC filings and registration

- **SEC name**: CNBX Pharmaceuticals Inc.

- **CIK**: 1343009

- **Industry (SIC)**: Pharmaceutical Preparations (2834)

- **US tickers**: CNBX (OTC)

- **State or country of incorporation**: NV

- **Fiscal year ends**: August 31

- **Filer category**: <br>Emerging growth company

- **Business address**: #3 BETHESDA METRO CENTER, BETHESDA, MD, 20814

- **Phone**: 877-424-2429

- **Shares outstanding**: 1,605,768,095 as of 2026-06-17 (10-Q filed 2026-06-24)

- **Former names**: Cannabics Pharmaceuticals Inc.; American Mining Corp; Thrust Energy Corp.

### Recent filings (8-K and 6-K are the company's own announcements)

- [8-K](https://www.sec.gov/Archives/edgar/data/1343009/000168316826007522/cnbx_8k.htm) filed 2026-10-01
- [10-Q](https://www.sec.gov/Archives/edgar/data/1343009/000168316826005078/cnbx_i10q-053126.htm) filed 2026-06-24
- [10-Q](https://www.sec.gov/Archives/edgar/data/1343009/000168316826002899/cnbx_i10q-22826.htm) filed 2026-04-14
- [8-K](https://www.sec.gov/Archives/edgar/data/1343009/000168316826001883/cnbx_8k.htm) filed 2026-03-17
- [10-Q](https://www.sec.gov/Archives/edgar/data/1343009/000168316826000285/cnbx_10q-113025.htm) filed 2026-01-14
- [10-K](https://www.sec.gov/Archives/edgar/data/1343009/000168316825008736/cnbx_i10k-083125.htm) filed 2025-12-01
- [10-Q](https://www.sec.gov/Archives/edgar/data/1343009/000168316825005075/cnbx_i10q-53125.htm) filed 2025-07-14
- [10-Q](https://www.sec.gov/Archives/edgar/data/1343009/000168316825002511/cnbx_i10q-022825.htm) filed 2025-04-14

Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001343009), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

## Listing details

CNBX Pharmaceuticals Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker CNBX, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: CNBX Pharmaceuticals Inc.

- **Ticker**: CNBX

- **Listing**: OTC

- **Country or territory**: United States

- **Business scope**: Biotechnology

- **ISIN**: US13764M2098

- **Last quote in directory**: 2026-10-21

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/OTC-CNBX/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/cnbx-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "CNBX Pharmaceuticals (CNBX) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/cnbx-pharmaceuticals/